Post-earnings recap
Reported
Tue, Jan 31, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Amgen's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. The stock reacted modestly, rising by 0.32%, likely reflecting investor confidence in the company's ongoing strategies and performance in key areas. However, the lack of revenue data and guidance leaves some uncertainty about future growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.09 | N/A | +1.34% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed confidence in the company's strategic direction. They emphasized the importance of innovation and market positioning.
Management highlighted strong performance in key therapeutic areas.
They noted ongoing investments in R&D to drive future growth.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—